Latest Regulatory Scrutiny News

The Takeovers Panel has refused to proceed with a disclosure dispute application related to Atlas Arteria’s off-market takeover bid and its handling of a right of first offer notice for the Chicago Skyway asset.

Thrive Tribe Technologies’ 1TTO securities face immediate suspension from ASX pending regulatory compliance, isolating the impact to this class alone amid ongoing capital raises.

Solvar Limited has renewed its on-market share buy-back for 12 months, signalling ongoing capital management amid evolving market conditions.

Tuas Limited has called off its planned acquisition of M1 Limited after failing to meet critical conditions by the extended deadline, while regulatory scrutiny intensifies around its subsidiary Simba Telecom.

Equity Trustees Superannuation Limited (ETSL) will contest ASIC's Federal Court civil proceedings related to the First Guardian Master Fund, where member losses total around $70 million. The trustee insists it acted within its fiduciary duties amid ongoing liquidation efforts.

Little Green Pharma (ASX:LGP) posted a 15.3% revenue increase to AUD 42.5 million in FY2026, driven by European market expansion, yet recorded a $1.4 million loss after tax impacted by significant inventory write-downs.

Elanor Investors Group has obtained an ASX waiver allowing it to delay issuing stapled securities as part of its acquisition of Singapore-based Firmus Capital until July 10, 2026, due to pending regulatory approvals.

Yowie Group has increased its secured working capital loan facility with Keybridge Capital from A$2.5 million to A$3.5 million, maintaining the maturity date at 31 August 2026. This latest amendment reflects ongoing efforts to shore up liquidity amid operational challenges.

The Australian Treasurer has mandated the disposal of over 1.6 billion shares held by foreign entities in Northern Minerals, intensifying regulatory scrutiny of foreign ownership in this critical rare earths company.

Diamond Infraco, backed by IFM Global Infrastructure Fund, has lodged a Takeovers Panel application alleging material disclosure deficiencies in Atlas Arteria's takeover bid documents, centering on governance rights tied to the Chicago Skyway asset.

WA Kaolin is seeking up to A$34.9 million through a fully underwritten entitlement offer aimed at restructuring its balance sheet, reducing shareholder loans, and funding operational improvements at its Wickepin kaolin project.

Chatham Rock Phosphate has secured a definitive financing agreement with Wetstone Global that doubles an existing loan to USD 300,000 and converts it into a 30% equity stake, granting Wetstone majority board control and potential for up to 70% ownership upon project milestones.